COLUMN GROUP II, LP - 30 Sep 2025 SCHEDULE 13G/A Report for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC)

Filing Manager
COLUMN GROUP II, LP
Reporting Manager
Peter Svennilson
Security
ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
ORIC
Shares outstanding
98,489,676 shares
Disclosed Ownership
3,644,118 shares
Ownership
3.7%
Form type
SCHEDULE 13G/A
Filing time
17 Nov 2025, 20:17:05 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Column Group II, LP 3.6% 3,540,777 0 3,540,777 /s/ James Evangelista, Attorney-in-Fact James Evangelista, Attorney-in-Fact
The Column Group II GP, LP 3.6% 3,540,777 0 3,540,777 /s/ James Evangelista, Attorney-in-Fact James Evangelista, Attorney-in-Fact
David V Goeddel 3.7% 3,627,493 86,716 3,540,777 /s/ James Evangelista, Attorney-in-Fact James Evangelista, Attorney-in-Fact
Peter Svennilson 3.7% 3,644,118 103,341 3,540,777 /s/ James Evangelista, Attorney-in-Fact James Evangelista, Attorney-in-Fact